| scholarly article | Q13442814 |
| P50 | author | Clifton Bogardus | Q64495509 |
| P2093 | author name string | Pratley RE | |
| Tataranni PA | |||
| Weyer C | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | insulin resistance | Q1053470 |
| Glucose | Q37525 | ||
| preproinsulin | Q7240673 | ||
| type 2 diabetes | Q3025883 | ||
| P304 | page(s) | 89-94 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Diabetes Care | Q5270111 |
| P1476 | title | Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development | |
| P478 | volume | 24 |
| Q46359825 | A Bayesian population analysis of the development of type 2 diabetes in the offspring of diabetic parents |
| Q37105231 | A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors |
| Q36248046 | Acute insulin response is an independent predictor of type 2 diabetes mellitus in individuals with both normal fasting and 2-h plasma glucose concentrations |
| Q50853616 | Advanced glycation end products (AGEs) are cross-sectionally associated with insulin secretion in healthy subjects. |
| Q36521097 | Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition |
| Q37591691 | Association between circulating adiponectin levels and polycystic ovarian syndrome |
| Q33901054 | Association of central adiposity with prediabetes and decreased insulin sensitivity in rural Chinese normal-weight and overweight women |
| Q46738317 | Associations between glucose tolerance, insulin sensitivity and insulin secretion phenotypes and polymorphisms in adiponectin and adiponectin receptor genes in the Quebec Family Study. |
| Q36811699 | Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study |
| Q37141727 | Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus |
| Q40391316 | Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study |
| Q35581227 | Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study |
| Q58778375 | Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes |
| Q28575171 | Class II phosphoinositide 3-kinase regulates exocytosis of insulin granules in pancreatic beta cells |
| Q37198163 | Comparison of the Usefulness of the Updated Homeostasis Model Assessment (HOMA2) with the Original HOMA1 in the Prediction of Type 2 Diabetes Mellitus in Koreans |
| Q51467442 | Components of metabolic syndrome predicting diabetes: no role of inflammation or dyslipidemia. |
| Q36987674 | Correlation between prediabetes conditions and microalbuminuria. |
| Q46698078 | Critical analysis on the use of the homeostasis model assessment (HOMA) indexes in the evaluation of the insulin resistance and the pancreatic beta cells functional capacity |
| Q33962117 | DNA methylation of microRNA-375 in impaired glucose tolerance |
| Q35111555 | Dapagliflozin: a sodium glucose cotransporter 2 inhibitor in development for type 2 diabetes |
| Q47921371 | Decline in the acute insulin response in relationship to plasma glucose concentrations |
| Q33602322 | Declining beta-cell compensation for insulin resistance in Hispanic women with recent gestational diabetes mellitus: association with changes in weight, adiponectin, and C-reactive protein |
| Q33610728 | Defining and characterizing the progression of type 2 diabetes |
| Q46087673 | Demographic and metabolic characteristics of individuals with progressive glucose tolerance. |
| Q39376494 | Depression and Anxiety Screens as Simultaneous Predictors of 10-Year Incidence of Diabetes Mellitus in Older Adults in Primary Care |
| Q28079718 | Dietary Interventions for Type 2 Diabetes: How Millet Comes to Help |
| Q46663806 | Differences in insulin sensitivity, pancreatic beta cell function and circulating adiponectin across glucose tolerance status in Thai obese and non-obese women |
| Q37268274 | Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus |
| Q26767164 | Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials |
| Q35997955 | Economics of diabetes-cost impact of not treating diabetes early and intensively |
| Q38178751 | Effect of insulin-induced hypoglycaemia on the central nervous system: evidence from experimental studies. |
| Q46882085 | Effect of metformin and rosiglitazone in a prepubertal boy with Alström syndrome |
| Q56089326 | Effect of multispecies probiotic supplements on serum minerals, liver enzymes and blood pressure in patients with type 2 diabetes |
| Q34424907 | Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes |
| Q33810525 | Effects of Synbiotic Food Consumption on Serum Minerals, Liver Enzymes, and Blood Pressure in Patients with Type 2 Diabetes: A Double-blind Randomized Cross-over Controlled Clinical Trial |
| Q37341703 | Effects of a culturally grounded community-based diabetes prevention program for obese Latino adolescents |
| Q35173918 | Effects of intensive insulin therapy upon pancreatic β cell function in patients newly diagnosed with type II diabetes |
| Q34527061 | Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial |
| Q35550422 | Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management |
| Q36072493 | Exenatide Treatment Alone Improves β-Cell Function in a Canine Model of Pre-Diabetes |
| Q51379636 | Expanding the clinical use of standard OGTT: the percentage increment of 2 h with respect to fasting glucose as an index of β-cell dysfunction. |
| Q36237838 | Gastric bypass alters the dynamics and metabolic effects of insulin and proinsulin secretion |
| Q35390039 | Glucoregulatory function among African Americans and European Americans with normal or pre-diabetic hemoglobin A1c levels |
| Q44427438 | Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome |
| Q51473378 | Glucose dysregulation in obese children: predictive, risk, and potential protective factors. |
| Q44639911 | Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men. |
| Q24299570 | HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion |
| Q35649246 | HOMA-IR Values are Associated With Glycemic Control in Japanese Subjects Without Diabetes or Obesity: The KOBE Study. |
| Q34545348 | High calorie intake is associated with worsening insulin resistance and β-cell function in Hispanic women after gestational diabetes mellitus. |
| Q43145348 | High-fat feeding and Staphylococcus intermedius infection impair beta cell function and insulin sensitivity in mongrel dogs |
| Q36667451 | Hydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases |
| Q35986206 | Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose tolerance |
| Q44064451 | Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects |
| Q51387527 | Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients |
| Q39988564 | Incretin effects on β-cell function, replication, and mass: the human perspective |
| Q36870045 | Inflammation and schizophrenia |
| Q44418226 | Insulin Resistant State in Type 2 Diabetes Is Related to Advanced Autonomic Neuropathy |
| Q33556828 | Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care |
| Q53736022 | Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease. |
| Q33556896 | Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: the Insulin Resistance Atherosclerosis Study |
| Q33854415 | Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men. |
| Q35688277 | Insulin secretion and its determinants in the progression of impaired glucose tolerance to type 2 diabetes in impaired glucose-tolerant individuals: the Finnish Diabetes Prevention Study |
| Q40389373 | K-value and low insulin secretion in a non-obese white population: predicted glucose tolerance after 25 years |
| Q39184989 | Knockout of arsenic (+3 oxidation state) methyltransferase is associated with adverse metabolic phenotype in mice: the role of sex and arsenic exposure |
| Q33570090 | Lack of racial disparity in incident prediabetes and glycemic progression among black and white offspring of parents with type 2 diabetes: the pathobiology of prediabetes in a biracial cohort (POP-ABC) study |
| Q40644407 | Lipid and inflammatory biomarker profiles in early insulin resistance. |
| Q51292888 | Long-term wheel-running and acute 6-h advances alter glucose tolerance and insulin levels in TALLYHO/JngJ mice. |
| Q38020015 | Managing diabetes from first diagnosis: choosing well-tolerated therapies with durability |
| Q57828071 | New Diagnostic Criteria, New Classification of Dm and Modern Therapy Approach |
| Q34766224 | Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation |
| Q27316871 | Oligomerization of Peptides LVEALYL and RGFFYT and Their Binding Affinity to Insulin |
| Q40140324 | One-hour and two-hour postload plasma glucose concentrations are comparable predictors of type 2 diabetes mellitus in Southwestern Native Americans. |
| Q91902967 | Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study |
| Q42365615 | Pancreatic imaging: Current status of clinical practices and small animal studies |
| Q36508881 | Pathobiology of Prediabetes in a Biracial Cohort (POP-ABC) study: baseline characteristics of enrolled subjects |
| Q37577162 | Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes |
| Q53872253 | Pathophysiology and long-term management of the metabolic syndrome. |
| Q38851396 | Peripheral insulin resistance rather than beta cell dysfunction accounts for geographical differences in impaired fasting blood glucose among sub-Saharan African individuals: findings from the RODAM study |
| Q37007558 | Persistence of the metabolic syndrome over 3 annual visits in overweight Hispanic children: association with progressive risk for type 2 diabetes |
| Q35687777 | Phylloquinone intake, insulin sensitivity, and glycemic status in men and women |
| Q50988205 | Pleiotropic effects of thiazolidinediones: implications for the treatment of patients with type 2 diabetes mellitus. |
| Q42849043 | Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus |
| Q37106937 | Prediabetes as a toxic environment for the initiation of microvascular and macrovascular complications |
| Q53864436 | Presence of metabolic risk factors in non-obese PCOS sisters: evidence of heritability of insulin resistance. |
| Q44527925 | Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome |
| Q39654274 | Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study |
| Q43782780 | Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome |
| Q36311249 | Preventing diabetes in obese Latino youth with prediabetes: a study protocol for a randomized controlled trial |
| Q37105207 | Primary defects in beta-cell function further exacerbated by worsening of insulin resistance mark the development of impaired glucose tolerance in obese adolescents |
| Q35087584 | Progression from IGT to type 2 diabetes mellitus: the central role of impaired early insulin secretion |
| Q44362519 | Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study |
| Q34810384 | Protein tyrosine phosphatase 1B inhibitors for diabetes |
| Q37167551 | Redefining the role of thiazolidinediones in the management of type 2 diabetes |
| Q36772169 | Reevaluation of the prevalence of metabolic syndrome in an urban area of Turkey |
| Q90655369 | Regression from prediabetes to normal glucose regulation: State of the science |
| Q37169408 | Relation of insulin resistance with social-demographics, adiposity and behavioral factors in non-diabetic adult Canadians. |
| Q51253651 | Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study. |
| Q65002577 | Resistance Exercise Training as a Primary Countermeasure to Age-Related Chronic Disease. |
| Q51285524 | Risk factors for postpartum glucose intolerance in women with gestational diabetes mellitus. |
| Q36131766 | Role of impaired insulin secretion and insulin resistance in the pathogenesis of type 2 diabetes mellitus |
| Q34248505 | SGLT-2 inhibitors in development for type 2 diabetes treatment |
| Q36957442 | Serum leptin level is reduced in non-obese subjects with type 2 diabetes |
| Q35123342 | Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and β-cell function in subjects with long-term remission |
| Q36044246 | Simultaneous measurement of insulin sensitivity, insulin secretion, and the disposition index in conscious unhandled mice |
| Q36988311 | Skeletal muscle-specific overexpression of SIRT1 does not enhance whole-body energy expenditure or insulin sensitivity in young mice |
| Q37270524 | Targeting Incretins in Type 2 Diabetes: Role of GLP-1 Receptor Agonists and DPP-4 Inhibitors |
| Q33618986 | The Imbalance of B-Lymphocyte Subsets in Subjects with Different Glucose Tolerance: Relationship with Metabolic Parameter and Disease Status |
| Q51389447 | The correlation between the oral glucose tolerance test 30-minutes plasma glucose and risk factors for diabetes and cardiovascular diseases: A cross-sectional epidemiological study of diabetes in Fujian Province in the South-East of China |
| Q81382053 | The effect of Helicobacter pylori on insulin resistance |
| Q38056783 | The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis |
| Q34768527 | The heritability of beta cell function parameters in a mixed meal test design |
| Q51365869 | The immune marker soluble urokinase plasminogen activator receptor is associated with new-onset diabetes in non-smoking women and men. |
| Q34227968 | The impact of effective continuous positive airway pressure on homeostasis model assessment insulin resistance in non-diabetic patients with moderate to severe obstructive sleep apnea |
| Q46569749 | The interaction between impaired acute insulin response and insulin resistance predict type 2 diabetes and impairment of fasting glucose |
| Q64971252 | The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses. |
| Q35909101 | The management of type 2 diabetic patients with hypoglycemic agents |
| Q37304741 | Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. |
| Q41777831 | Treatment of obesity in children and adolescents |
| Q26783350 | Treatment of prediabetes |
| Q27694430 | Type 2 diabetes can be prevented with early pharmacological intervention |
| Q39738765 | Type 2 diabetes in non-obese Indian subjects is associated with reduced leptin levels: study from Mumbai, Western India |
| Q47169055 | Water T2 as an early, global and practical biomarker for metabolic syndrome: an observational cross-sectional study |
| Q38241464 | What are the pharmacotherapy options for treating prediabetes? |
| Q36947018 | beta-cell function and anti-diabetic pharmacotherapy |
Search more.